ASSET PURCHASE AGREEMENT CENTOCOR, INC (“SELLER”) ESP PHARMA, INC. (“BUYER”) January 31, 2005Asset Purchase Agreement • March 25th, 2005 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 25th, 2005 Company Industry JurisdictionThis Asset Purchase Agreement (the “Agreement”) is entered into as of this 31st day of January, 2005 (the “Effective Date”) between Centocor, Inc., a Pennsylvania corporation having its headquarters at 200 Great Valley Parkway, Malvern, PA 19355 (“SELLER”), and ESP Pharma, Inc. a Delaware corporation, having its headquarters at 2035 Lincoln Highway, Suite 2150, Edison, New Jersey 08817 (“BUYER”).